Skip to main content
High RiskFDAfda-F-1286-2013OTHER

Propolis Powder -100% Standardized Bee-Propolis Lot #: 021113-55/60, EXP: 10/14 11# Bag & Lot#: 10081155/60-120612-100, EXP: 12/15, 1# BAG.

Category
Units Affected
4,615
Recall Date
March 1, 2013
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1286-2013.

Beehive Botanical, Inc is recalling several lots of Propolis 55-60% due to positive identification of Fluvalinate.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1286-2013.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Beehive Botanicals, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1286-2013.

Beehive Botanicals, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Beehive Botanicals, Inc. Recall FAQ

Beehive Botanicals, Inc. is the subject of a food safety report: Propolis Powder -100% Standardized Bee-Propolis Lot #: 021113-55/60, EXP: 10/14 11# Bag & Lot#: 10081155/60-120612-100, EXP: 12/15, 1# BAG.. The notice was published on March 1, 2013 by the U.S. Food and Drug Administration (FDA). Approximately 4,615 units are potentially affected.